Renal oncocytoma biopsy: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) |
Shanshan Cen (talk | contribs) |
||
| Line 18: | Line 18: | ||
:* [[AMACR]] ([[Racemase]]) - | :* [[AMACR]] ([[Racemase]]) - | ||
:* S100 + | :* S100 + | ||
:* | :* [[CD117]] + | ||
:* Cadherin-E + | :* Cadherin-E + | ||
:* [[TFE3]] - | :* [[TFE3]] - | ||
Revision as of 19:16, 28 October 2015
|
Renal oncocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal oncocytoma biopsy On the Web |
|
American Roentgen Ray Society Images of Renal oncocytoma biopsy |
|
Risk calculators and risk factors for Renal oncocytoma biopsy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
On biopsy, renal oncocytoma is characterized by oncocytes and large eosinophilic cells.
Biopsy
- On biopsy, renal oncocytoma is characterized by oncocytes and large eosinophilic cells.
- Biopsy is insufficient to distinguish renal oncocytoma from renal cell carcinoma, therefore immunostaining may be required.[1]
- Immunohistochemical profile[2]
References
- ↑ Liu J, Fanning CV (2001). "Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies". Cancer. 93 (6): 390–7. PMID 11748579.
- ↑ [Renal Neoplasms: An Update on Immunohistochemical and Histochemical Features http://www.dako.com/08066_12may10_webchapter26.pdf]